CARDIOPROTECTIVE EFFICACY OF TAURINE ON LIPID-METABOLISM OF ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION
DOI:
https://doi.org/10.22159/ijpps.2016v8i12.14966Keywords:
Taurine, isoproterenol (ISO), cardiac biomarker enzymes, lipid profile, antioxidant defense system, myocardial infarctionAbstract
Objective: The present study aimed to evaluate the effect of pre-treatment with taurine on rats in which MI had been induced using isoproterenol (ISO).
Methods: Rats were randomly allocated into three groups; the 1st group is the normal control (C) one, the 2nd is the isoproterenol cardiotoxic (ISO) one and the 3rd group is the taurine pretreated (T-ISO) one.
Results: The activities of the cardiac biomarker enzymes, AST, LDH, CK and CK-MB were elevated in the ISO-treated group. The membrane-bound  Na+-K+ and Ca2+ ATPase enzyme activities were decreased in the ISO-treated group. The lipid profile either in sera or cardiac tissues was increased in ISO-treated rats except for HDL-cholesterol and phospholipids. The cholesterol ester synthetase (CES) activity was elevated, while lecithin: Cholesterol acyltransferase (LCAT) and lipoprotein lipase (LPL) activities were decreased in the myocardial infarcted rats. In addition, the high level of the troponins I and T was an indication of cardiac necrosis. Pre-treatment with Taurine, however, ameliorated all of these changes, in addition to its effect in improving the oxidation process, as measured by lipid peroxidation and the antioxidant enzymes, superoxide dismutase and peroxidase enzymes.
Conclusion: Taurine showed amelioration effects on the changes in lipid profile, oxidative stress and myocardial infarction biomarkers and therefore, can be protected against cardiotoxicity.
Downloads
References
Glew RH, Kassam HA, Bhanji RA, Okorodudu A, VanderJagt DJ. Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria. J Health Popul Nutr 2002;20:166-74.
Nair PS, Devi CS. Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol-induced cardiotoxicity. Toxicology 2006;228:135-9.
Benelli R, Venè R, Bisacchi D, Garbisa S, Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 2002;383:101-5.
Valen G. Cellular signaling mechanisms in adaptation to ischemia-induced myocardial damage. Ann Med 2003;35:300-7.
Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium–apoptosis link. Nat Rev Mol Cell Biol 2003;4:552-65.
Antman EM. Decision-making with cardiac troponin tests. New England J Med 2002;346:2079–82.
Metzger JM, Westfall MV. Covalent and non-covalent modification of thin filament action the essential role of troponin in cardiac muscle regulation. Circ Res 2004;94:146-58.
Kurata M, Iidaka T, Sasayama Y, Fukushima T, Sakimura M. Correlation among clinicopathological parameters of myocardial damage in rats treated with isoproterenol. Exp Anim 2007;56:57-62.
Raiha N, Rassin D, Heinonen K, Gaull GE. Milk protein quality and quantity: Biochemical and growth effects in low birth weight infants (LBWI). Pediatr Res 1975;9:370.
Birdsall TC. Therapeutic applications of taurine. Alternative Med Rev 1998;3:128-36.
Ito T, Sw Fau–Azuma JS, Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 2012;42:1529-39.
Lourenco R, Camilo M. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 2002;17:262-70.
Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, et al. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 2002;16:231-3.
Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 2004;45:776-8.
Parcell S. Sulfur in human nutrition and applications in medicine. Alternative Med Rev 2002;7:22-44.
Lombardini JB, Militante JD. Effects of taurine supplementation on cholesterol levels with potential ramification in atherosclerosis. Adv Exp Med Biol 2006;583:251-4.
Allard ML, Jeejeebhoy KN, Sole MJ. The management of conditioned nutritional requirements in heart failure. Heart Failure Rev 2006;11:75-82.
El-Agousa IMA, El-Nashar DE, Eissa SS, Sharoud MN. Possible ameliorative effect of antioxidant (Taurine) in pregnant toxemic female Rats. Open Hypertens J 2009;2:1-15.
Kim K, Kim SH, Kim J, Kim H, Yim J. Glutathione s-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease. J Biol Chem 2012;287:6628-41.
Subashini R. Cardioprotective efficacy of nelumbo nucifera leaf extract on a glycoprotein, membrane bound ATPase and lysosomal enzymes against isoproterenol induced cardiotoxicity in wistar rats. Int J Pharm Pharm Sci 2014;6:537-41.
Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 2003;327:69-79.
Young DS. Effects of drugs on clinical laboratory tests. 4th ed. AACC Press Washington; 1995.
Okinaka S, Kumagai H, Ebashi S, Sugita H, Momoi H. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol 1961;4:520-5.
Young D. Effects of drugs on clinical laboratory tests. Ann Clin Biochem 1997;34:579.
Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
Connerty HF, Briggs AR, Eaton EH. Simplified determination of the lipid components of blood serum. Clin Chem 1961;7:37-53.
Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005;142:403-11.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population the Copenhagen city heart study. Circulation 2008;117:176-84.
Guido S., Joseph T. Effect of chemically different calcium antagonists on lipid profile in rats fed on a high-fat diet. Indian J Exp Biol 1992;30:292-4.
Bhaskar I, Rao SB. New, a simple and cheap alternative to troponin test for diagnosis of acute myocardial infarction. Indian J Exp Biol 2002;40:628-30.
Kothari HV, Miller BF, Kritchevsky D. Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochim Biophys Acta 1973;296:446-54.
Hitz J, Steinmetz J, Siest G. Plasma lecithin: cholesterol acyltransferase-reference values and effects of xenobiotics. Clin Chim Acta 1983;133:85-96.
Salter AM, White DA. Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentrations. Nutr Res Rev 1996;9:241-57.
Swann AC, Steketee JD. Subacute noradrenergic agonist infusions in vivo increase Na+, K+-ATPase, and ouabain binding in rat cerebral cortex. J Neurochem 1989;52:1598-604.
Ohnishi T, Suzuki T, Suzuki Y, Ozawa K. A comparative study of plasma membrane Mg2+-ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta 1982;684:67-74.
Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA. Comparative effects of chromium, vanadium, and Gymnema Sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 1998;17:116-23.
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-74.
Kar M, Mishra D. Catalase, peroxidase, and polyphenol oxidase activities during rice leaf senescence. Plant Physiol 1976;57:315-9.
Devika PT, Prince PSM. Preventive effect of (-) epigallocatechin gallate on lipids, lipoproteins, and enzymes of lipid metabolism in isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2009;23:387-93.
Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 2004;94:184-90.
Czubryt MP. Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrog Tissue Repair 2012;5:19.
Ziaee M, Khorrami A, Ebrahimi M, Nourafcan H, Amiraslanzadeh M. Cardioprotective effects of essential oil of lavandula angustifolia on isoproterenol-induced acute myocardial infarction in rat. Iranian J Pharm Res 2015;14:279–89.
Brooks WW, Conrad CH. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. Compens Med 2009;59:339.
Lombardini JB. Taurine depletion in the intact animal stimulates in vitro phosphorylation of a 44-kDa protein present in the mitochondrial fraction of the rat heart. J Mol Cell Cardiol 1996;28:1957-61.
Kim, SJ, RC Gupta, HW Lee. Taurine-diabetes interaction: from involvement to protection. Curr Diabetes Rev 2007;3:165-75.
Warskulat U, Flögel U, Jacoby C, Hartwig HG, Thewissen M. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 2004;18:577-9.
Ohta H, Azuma J, Awata N, Hamaguchi T, Tanaka Y. Mechanism of the protective action of taurine against isoprenaline-induced myocardial damage. Cardiovasc Res 1988;22:407-13.
Shi Y, Qi YF, Bu DF, Gao L, Wang DY. Dysfunction of myocardial and vascular taurine transport in spontaneously hypertensive rats. Shengli Xuebao 2002;54:359-64.
Aidi W, Yang Z, Lu M, Jianmin H, Yaochuan L. Role of antioxidant activity of taurine in diabetes. Mod J Animal Husbandry Vet Med 2011;4:34.
Meng D, Feng L, Chen XJ, Yang D, Zhang JN. Trimetazidine improved Ca2+handling in isoprenaline mediated myocardial injury of rats. Exp Physiol 2006;91:591-601.
Ramatulla M, Devi KL. Origination and development of isoproterenol-induced myocardial infarction in male wastar rats. Int Res J Pharm 2013;4:26-35.
Sudha M, Rajkumar D, Felix JW. Protective effect of glutathione against isoproterenol-induced myocardial injury in rats. Indian J Physiol Pharmacol 2013;57:132-7.
Upaganlawar A, Gandhi H, Balaraman R. Isoproterenol-induced myocardial infarction: protective role of natural products. J Pharmacol Toxicol 2011;6:1-17.
Schaffer S, Fau–Azuma JTK, Azuma J. Role of osmoregulation in the actions of taurine. J Physiol Sci 2000;16:17-20.
Davuluri G, Seiler C, Abrams J, Soriano AJ, Pack M. Differential effects of thin and thick filament disruption on zebrafish smooth muscle regulatory proteins: Zebrafish smooth muscle regulatory proteins. Neurogastroenterol Motil 2010;22:1100-e285.
Schaffer S, Ramila KC, Jong CJ, Ito T, Azuma J. Role of protein phosphorylation in TauTKO cardiomyopathy [abstract]. Int Taurine Symp; 2009.
Rapundalo ST. Cardiac protein phosphorylation: functional and pathophysiological correlates. Cardiovasc Res 1998;38:559-88.
Park Y, Kanekal S, Kehrer JP. Oxidative changes in hypoxic rat heart tissue. Am J Physiol 1991;260:H1395-405.
Jia LG, Donnet C, Bogaev RC, Blatt RJ, McKinney CE. Hypertrophy increased ejection fraction and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am J Physiol: Heart Circ Physiol 2005;288:H1982-8.
Ripps H, Shen W. Review: taurine: a very essential†amino acid. Mol Vision 2012;18:2673–86.
Nigam P, Narain V, Hasan M. Serum lipid profile in patients with acute myocardial infarction. Indian J Clin Biochem 2004;19:67-70.
Farvin KS, Anandan R, Kumar SH, Shiny KS, Mathew S. Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats. J Med Food 2006;9:531-6.
Asha K, Anandan R, Nair P. Effect of fish protein on isoprenaline-induced alterations in lipid and antioxidant status in adipose tissue of rats. Indian J fischaries 2008;45:63-72.
Vijayakumar M, Selvi V, Krishnakumari S. Efficacy of Lagenaria siceraria (MOL) on Lipid profile in isoproterenol-induced mycardial infarction in wistar rats. Int J Pharma Bio Sci 2010;1:295-300.
Deepa P, Varalakshmi P. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycan -uria and tissue lipid abnormalities. Toxicology 2005;211:77-85.
Yogeeta SK, Hanumantra RB, Gnanapragasam A, Senthilkumar S, Subhashini R. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Basic Clin Pharmacol Toxicol 2006;98:467-72.
Wei B, You MG, Ling JJ, Wei LL, Wang K. Regulation of the antioxidant system, lipids, and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats. Atherosclerosis 2013;230:148-56.
Rashba-Step J, Tatoyan A, Duncan R, Ann D, Pushpa-Rehka TR. Phospholipid peroxidation induces cytosolic phospholipase A 2 activity: membrane effects versus enzyme phosphorylation. Arch Biochem Biophys 1997;343:44-54.
Upaganlawar A, Balaraman R. Combined effect of green tea extract and vitamin e on serum and heart tissue lipids, lipid metabolizing enzymes and histopathological alteration in isoproterenol-induced myocardial infarction in rats. Sci Pharm 2009;77:791-803.
Radhika J, Surya S, Jothi G, Japasheba JL. The cardioprotective role of justicia traquebareinsis Linn. Leaf extract in isoproterenol induced myocardial infarction in albino rats. J Appl Pharm Sci 2013;3:124-8.
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D. Biomembranes and the subcellular organization of eukaryotic cells. In: Molecular Cell Biology. 4th edn. New York: WH. Freeman; 2000.
Al-Yahya MA, Mothana RA, Al-Said MS, El-Tahir KA, Al-Sohaibani M. Citrus medica Otrojâ€: attenuates oxidative stress and cardiac dysrhythmia in isoproterenol-induced cardiomyopathy in rats. Nutrients 2013;5:4269-83.
Pereira T. Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular disease. INTECH Open Access Publisher; 2012.
Militante JD, Lombardini JB. Dietary taurine supplementation: hypolipidemic and antiatherogenic effects. Nutr Res 2004;24:787-801.
Du H, You JS, Zhao X, Park JY, Kim SH. Antiobesity and hypolipidemic effects of lotus leaf hot water extract with taurine supplementation in rats fed a high-fat diet. J Biomed Sci 2010;17:S42.
Saleh AAS. Effects of taurine and/or ginseng and their mixture on lipid profile and some parameters indicative of myocardial status in streptozotocin-diabetic rats. J Basic Appl Zool 2012;65:267-73.
Huxtable R. Physiological actions of taurine. Physiol Rev 1992;72:101-63.
Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses the development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 2002;163:79-87.
Eilertsen KE, Larsen R, HaMæhre HK, Jensen IJ, Elvevoll EO. Anticholesterolemic and antiatherogenic effects of taurine supplementation is model dependent. In: "Lipoproteins-Role in Health and Diseases," book edited by Sasa Frank and Gerhard Kostner, InTechOpen; 2012.
Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses the development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 2002;163:79-87.
Heibashy M. Effect of vanadium and taurine on lipid profile and some parameters indicative of myocardial status in male rats with streptozotocin-induced diabetes. J Egypt Ger Soc Zoology 2005;47:117-38.
Chen W, Guo JK, Chang P. The effect of taurine on cholesterol metabolism. Mol Nutr Food Res 2012;56:681-90.
Chen W, Matuda K, Nishimura N, Yokogoshi H. The effect of taurine on cholesterol degradation in mice fed a high cholesterol diet. Life Sci 2004;74:1889-98.
Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004;89:4607-14.